{"id":9408,"date":"2024-01-23T07:16:25","date_gmt":"2024-01-23T07:16:25","guid":{"rendered":"https:\/\/dailyai.com\/?p=9408"},"modified":"2024-01-23T07:16:25","modified_gmt":"2024-01-23T07:16:25","slug":"fda-approves-dermasensors-ai-skin-cancer-detector","status":"publish","type":"post","link":"https:\/\/dailyai.com\/it\/2024\/01\/fda-approves-dermasensors-ai-skin-cancer-detector\/","title":{"rendered":"L'FDA approva il rilevatore di tumori della pelle AI di DermaSensor"},"content":{"rendered":"

La FDA ha approvato la vendita negli Stati Uniti del rilevatore portatile di tumori della pelle con intelligenza artificiale di DermaSensor.<\/strong><\/p>\n

Il cancro della pelle \u00e8 il tumore pi\u00f9 comune al mondo: circa un americano su cinque ne sviluppa uno nel corso della propria vita. La forma pi\u00f9 grave di cancro della pelle, il melanoma, uccide circa 9.000 americani ogni anno.<\/p>\n

Circa il 99% dei tumori della pelle sono curabili, ma spesso non vengono individuati finch\u00e9 non \u00e8 troppo tardi. I dermatologi scarseggiano e pu\u00f2 essere difficile per un medico di base (PCP) distinguere tra un neo benigno e un cancro della pelle.<\/p>\n

DermaSensor ha progettato un dispositivo portatile non invasivo in grado di rilevare le tre forme pi\u00f9 comuni di cancro della pelle: melanoma, carcinoma basocellulare e carcinoma squamocellulare.<\/p>\n

Il dispositivo utilizza la spettroscopia a diffusione elastica (ESS), una tecnica di biopsia ottica non invasiva. Quando la punta del dispositivo viene tenuta in contatto con la lesione cutanea sospetta, essa vi pulsa attraverso diverse lunghezze d'onda della luce e cattura gli spettri risultanti.<\/p>\n

Utilizza quindi un algoritmo per analizzare gli spettri e determinare se la lesione \u00e8 maligna o benigna.<\/p>\n

https:\/\/youtu.be\/yUaEgpMj8SY<\/p>\n

L'algoritmo \u00e8 stato addestrato con oltre 20.000 scansioni spettrali provenienti da pi\u00f9 di 4.500 lesioni cutanee, utilizzando una rete feedforward e due reti neurali profonde. Una volta addestrato sulle scansioni spettrali etichettate, il dispositivo ha imparato a capire se una nuova scansione spettrale era cancerosa e di che tipo di cancro della pelle si trattava.<\/p>\n

Il dispositivo identifica positivamente il cancro della pelle con un'accuratezza di 96%, mentre identifica correttamente le lesioni benigne nel 97% dei casi. Queste cifre sono significativamente migliori di quelle ottenute dai PCP nei loro studi.<\/p>\n

\"\"
Accuratezza di DermaSensor nel rilevare il melanoma e il cancro della pelle non melanoma rispetto ai medici di base umani. Fonte: DermaSensor<\/figcaption><\/figure>\n

Il dispositivo sar\u00e0 disponibile attraverso un modello di abbonamento a $199 al mese per cinque pazienti o $399 al mese per un uso illimitato.<\/p>\n

DermaSensor consentir\u00e0 ai medici di base di determinare rapidamente se il loro paziente debba essere indirizzato a un dermatologo. Inoltre, ridurr\u00e0 gli invii inutili di pazienti a specialisti per poi scoprire che il PCP, troppo cauto, ha identificato erroneamente una lesione benigna.<\/p>\n

Questo \u00e8 uno dei numerosi rilevamento del cancro<\/a> e soluzioni di trattamento<\/a> che l'intelligenza artificiale ha reso possibile.<\/p>","protected":false},"excerpt":{"rendered":"

La FDA ha approvato la vendita negli Stati Uniti del rilevatore portatile di tumori della pelle alimentato dall'intelligenza artificiale di DermaSensor. Il cancro della pelle \u00e8 il tumore pi\u00f9 comune al mondo: circa un americano su cinque ne sviluppa uno nel corso della propria vita. La forma pi\u00f9 grave di cancro della pelle, il melanoma, uccide circa 9.000 americani ogni anno. Circa il 99% dei tumori della pelle sono curabili, ma spesso non vengono individuati finch\u00e9 non \u00e8 troppo tardi. I dermatologi scarseggiano e pu\u00f2 essere difficile per un medico di base (PCP) distinguere tra un neo benigno e un cancro della pelle. DermaSensor ha progettato<\/p>","protected":false},"author":6,"featured_media":9423,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[83],"tags":[150,101],"class_list":["post-9408","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-product","tag-ai-benefits","tag-medtech"],"yoast_head":"\nFDA approves DermaSensor\u2019s AI skin cancer detector | DailyAI<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/dailyai.com\/it\/2024\/01\/fda-approves-dermasensors-ai-skin-cancer-detector\/\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FDA approves DermaSensor\u2019s AI skin cancer detector | DailyAI\" \/>\n<meta property=\"og:description\" content=\"The FDA has given its approval for DermaSensor\u2019s AI-powered handheld skin cancer detector to be sold in the US. Skin cancer is the most common cancer in the world with around one in five Americans developing skin cancer in their lifetime. The most serious form of skin cancer, melanoma, kills about 9,000 Americans each year. About 99% of skin cancers are curable, but they often go undetected until it\u2019s too late. Dermatologists are in short supply and it can be difficult for a primary care physician (PCP) to tell the difference between a benign mole and skin cancer. DermaSensor designed\" \/>\n<meta property=\"og:url\" content=\"https:\/\/dailyai.com\/it\/2024\/01\/fda-approves-dermasensors-ai-skin-cancer-detector\/\" \/>\n<meta property=\"og:site_name\" content=\"DailyAI\" \/>\n<meta property=\"article:published_time\" content=\"2024-01-23T07:16:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/dailyai.com\/wp-content\/uploads\/2024\/01\/skin-cancer-examination.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"667\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Eugene van der Watt\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DailyAIOfficial\" \/>\n<meta name=\"twitter:site\" content=\"@DailyAIOfficial\" \/>\n<meta name=\"twitter:label1\" content=\"Scritto da\" \/>\n\t<meta name=\"twitter:data1\" content=\"Eugene van der Watt\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo di lettura stimato\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minuti\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/fda-approves-dermasensors-ai-skin-cancer-detector\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/fda-approves-dermasensors-ai-skin-cancer-detector\\\/\"},\"author\":{\"name\":\"Eugene van der Watt\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#\\\/schema\\\/person\\\/7ce525c6d0c79838b7cc7cde96993cfa\"},\"headline\":\"FDA approves DermaSensor\u2019s AI skin cancer detector\",\"datePublished\":\"2024-01-23T07:16:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/fda-approves-dermasensors-ai-skin-cancer-detector\\\/\"},\"wordCount\":369,\"publisher\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/fda-approves-dermasensors-ai-skin-cancer-detector\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/skin-cancer-examination.jpg\",\"keywords\":[\"AI benefits\",\"MedTech\"],\"articleSection\":[\"Product\"],\"inLanguage\":\"it-IT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/fda-approves-dermasensors-ai-skin-cancer-detector\\\/\",\"url\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/fda-approves-dermasensors-ai-skin-cancer-detector\\\/\",\"name\":\"FDA approves DermaSensor\u2019s AI skin cancer detector | DailyAI\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/fda-approves-dermasensors-ai-skin-cancer-detector\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/fda-approves-dermasensors-ai-skin-cancer-detector\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/skin-cancer-examination.jpg\",\"datePublished\":\"2024-01-23T07:16:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/fda-approves-dermasensors-ai-skin-cancer-detector\\\/#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/fda-approves-dermasensors-ai-skin-cancer-detector\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/fda-approves-dermasensors-ai-skin-cancer-detector\\\/#primaryimage\",\"url\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/skin-cancer-examination.jpg\",\"contentUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/skin-cancer-examination.jpg\",\"width\":1000,\"height\":667},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/fda-approves-dermasensors-ai-skin-cancer-detector\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/dailyai.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FDA approves DermaSensor\u2019s AI skin cancer detector\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#website\",\"url\":\"https:\\\/\\\/dailyai.com\\\/\",\"name\":\"DailyAI\",\"description\":\"Your Daily Dose of AI News\",\"publisher\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/dailyai.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"it-IT\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#organization\",\"name\":\"DailyAI\",\"url\":\"https:\\\/\\\/dailyai.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Daily-Ai_TL_colour.png\",\"contentUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Daily-Ai_TL_colour.png\",\"width\":4501,\"height\":934,\"caption\":\"DailyAI\"},\"image\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/DailyAIOfficial\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/dailyaiofficial\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@DailyAIOfficial\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#\\\/schema\\\/person\\\/7ce525c6d0c79838b7cc7cde96993cfa\",\"name\":\"Eugene van der Watt\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/Eugine_Profile_Picture-96x96.png\",\"url\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/Eugine_Profile_Picture-96x96.png\",\"contentUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/Eugine_Profile_Picture-96x96.png\",\"caption\":\"Eugene van der Watt\"},\"description\":\"Eugene comes from an electronic engineering background and loves all things tech. When he takes a break from consuming AI news you'll find him at the snooker table.\",\"sameAs\":[\"www.linkedin.com\\\/in\\\/eugene-van-der-watt-16828119\"],\"url\":\"https:\\\/\\\/dailyai.com\\\/it\\\/author\\\/eugene\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"La FDA approva il rilevatore di tumori cutanei AI di DermaSensor | DailyAI","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/dailyai.com\/it\/2024\/01\/fda-approves-dermasensors-ai-skin-cancer-detector\/","og_locale":"it_IT","og_type":"article","og_title":"FDA approves DermaSensor\u2019s AI skin cancer detector | DailyAI","og_description":"The FDA has given its approval for DermaSensor\u2019s AI-powered handheld skin cancer detector to be sold in the US. Skin cancer is the most common cancer in the world with around one in five Americans developing skin cancer in their lifetime. The most serious form of skin cancer, melanoma, kills about 9,000 Americans each year. About 99% of skin cancers are curable, but they often go undetected until it\u2019s too late. Dermatologists are in short supply and it can be difficult for a primary care physician (PCP) to tell the difference between a benign mole and skin cancer. DermaSensor designed","og_url":"https:\/\/dailyai.com\/it\/2024\/01\/fda-approves-dermasensors-ai-skin-cancer-detector\/","og_site_name":"DailyAI","article_published_time":"2024-01-23T07:16:25+00:00","og_image":[{"width":1000,"height":667,"url":"https:\/\/dailyai.com\/wp-content\/uploads\/2024\/01\/skin-cancer-examination.jpg","type":"image\/jpeg"}],"author":"Eugene van der Watt","twitter_card":"summary_large_image","twitter_creator":"@DailyAIOfficial","twitter_site":"@DailyAIOfficial","twitter_misc":{"Scritto da":"Eugene van der Watt","Tempo di lettura stimato":"2 minuti"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/dailyai.com\/2024\/01\/fda-approves-dermasensors-ai-skin-cancer-detector\/#article","isPartOf":{"@id":"https:\/\/dailyai.com\/2024\/01\/fda-approves-dermasensors-ai-skin-cancer-detector\/"},"author":{"name":"Eugene van der Watt","@id":"https:\/\/dailyai.com\/#\/schema\/person\/7ce525c6d0c79838b7cc7cde96993cfa"},"headline":"FDA approves DermaSensor\u2019s AI skin cancer detector","datePublished":"2024-01-23T07:16:25+00:00","mainEntityOfPage":{"@id":"https:\/\/dailyai.com\/2024\/01\/fda-approves-dermasensors-ai-skin-cancer-detector\/"},"wordCount":369,"publisher":{"@id":"https:\/\/dailyai.com\/#organization"},"image":{"@id":"https:\/\/dailyai.com\/2024\/01\/fda-approves-dermasensors-ai-skin-cancer-detector\/#primaryimage"},"thumbnailUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2024\/01\/skin-cancer-examination.jpg","keywords":["AI benefits","MedTech"],"articleSection":["Product"],"inLanguage":"it-IT"},{"@type":"WebPage","@id":"https:\/\/dailyai.com\/2024\/01\/fda-approves-dermasensors-ai-skin-cancer-detector\/","url":"https:\/\/dailyai.com\/2024\/01\/fda-approves-dermasensors-ai-skin-cancer-detector\/","name":"La FDA approva il rilevatore di tumori cutanei AI di DermaSensor | DailyAI","isPartOf":{"@id":"https:\/\/dailyai.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/dailyai.com\/2024\/01\/fda-approves-dermasensors-ai-skin-cancer-detector\/#primaryimage"},"image":{"@id":"https:\/\/dailyai.com\/2024\/01\/fda-approves-dermasensors-ai-skin-cancer-detector\/#primaryimage"},"thumbnailUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2024\/01\/skin-cancer-examination.jpg","datePublished":"2024-01-23T07:16:25+00:00","breadcrumb":{"@id":"https:\/\/dailyai.com\/2024\/01\/fda-approves-dermasensors-ai-skin-cancer-detector\/#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/dailyai.com\/2024\/01\/fda-approves-dermasensors-ai-skin-cancer-detector\/"]}]},{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/dailyai.com\/2024\/01\/fda-approves-dermasensors-ai-skin-cancer-detector\/#primaryimage","url":"https:\/\/dailyai.com\/wp-content\/uploads\/2024\/01\/skin-cancer-examination.jpg","contentUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2024\/01\/skin-cancer-examination.jpg","width":1000,"height":667},{"@type":"BreadcrumbList","@id":"https:\/\/dailyai.com\/2024\/01\/fda-approves-dermasensors-ai-skin-cancer-detector\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/dailyai.com\/"},{"@type":"ListItem","position":2,"name":"FDA approves DermaSensor\u2019s AI skin cancer detector"}]},{"@type":"WebSite","@id":"https:\/\/dailyai.com\/#website","url":"https:\/\/dailyai.com\/","name":"DailyAI","description":"La vostra dose quotidiana di notizie sull'intelligenza artificiale","publisher":{"@id":"https:\/\/dailyai.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dailyai.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"it-IT"},{"@type":"Organization","@id":"https:\/\/dailyai.com\/#organization","name":"DailyAI","url":"https:\/\/dailyai.com\/","logo":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/dailyai.com\/#\/schema\/logo\/image\/","url":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/06\/Daily-Ai_TL_colour.png","contentUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/06\/Daily-Ai_TL_colour.png","width":4501,"height":934,"caption":"DailyAI"},"image":{"@id":"https:\/\/dailyai.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/DailyAIOfficial","https:\/\/www.linkedin.com\/company\/dailyaiofficial\/","https:\/\/www.youtube.com\/@DailyAIOfficial"]},{"@type":"Person","@id":"https:\/\/dailyai.com\/#\/schema\/person\/7ce525c6d0c79838b7cc7cde96993cfa","name":"Eugene van der Watt","image":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/Eugine_Profile_Picture-96x96.png","url":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/Eugine_Profile_Picture-96x96.png","contentUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/Eugine_Profile_Picture-96x96.png","caption":"Eugene van der Watt"},"description":"Eugene proviene da un background di ingegneria elettronica e ama tutto ci\u00f2 che \u00e8 tecnologico. Quando si prende una pausa dal consumo di notizie sull'intelligenza artificiale, lo si pu\u00f2 trovare al tavolo da biliardo.","sameAs":["www.linkedin.com\/in\/eugene-van-der-watt-16828119"],"url":"https:\/\/dailyai.com\/it\/author\/eugene\/"}]}},"_links":{"self":[{"href":"https:\/\/dailyai.com\/it\/wp-json\/wp\/v2\/posts\/9408","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dailyai.com\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dailyai.com\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dailyai.com\/it\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/dailyai.com\/it\/wp-json\/wp\/v2\/comments?post=9408"}],"version-history":[{"count":3,"href":"https:\/\/dailyai.com\/it\/wp-json\/wp\/v2\/posts\/9408\/revisions"}],"predecessor-version":[{"id":9426,"href":"https:\/\/dailyai.com\/it\/wp-json\/wp\/v2\/posts\/9408\/revisions\/9426"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dailyai.com\/it\/wp-json\/wp\/v2\/media\/9423"}],"wp:attachment":[{"href":"https:\/\/dailyai.com\/it\/wp-json\/wp\/v2\/media?parent=9408"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dailyai.com\/it\/wp-json\/wp\/v2\/categories?post=9408"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dailyai.com\/it\/wp-json\/wp\/v2\/tags?post=9408"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}